Monday, July 25, 2016 1:55:23 PM
Medtronic anticipates approval in the spring next year. If approved, it will be the world's first "artificial pancreas." The system comprises Medtronic's MiniMed 670G insulin pump, fourth-generation glucose monitors and a control algorithm. The sensors are worn for 7 days before they need recharging, while the insulin pump needs to be refilled every three days, Bloomberg reported.
The submission is based on pivotal data, which Medtronic presented to the American Diabetes Association conference earlier this month. The data showed that the system helped to lower A1c levels and maintain more consistent blood glucose sensor values in 124 patients with Type 1 diabetes. No adverse events were reported in the study, which spanned 12,389 patient days. At the end of the study, most of the patients chose to join the continued-access program for the device.
A separate study involving 12 adults and 16 adolescents showed that overnight use of the closed-loop system reduced the time adults needed to get to their target glucose range and decreased nocturnal hypoglycemia for the adolescents.
Medtronic is leading the race to get an artificial pancreas to market, but the device giant isn't stopping there. It is working on a fully closed-loop system using its new Harmony 1 sensor, which is expected to last 10 days. The company also expects it to be more accurate and require just one calibrating finger-stick a day, rather than the twice-daily requirement of most continuous glucose monitors.
The artificial pancreas could ramp up Medtronic's diabetes business, which booked $496 million in revenues in the most recent quarter, which ended May 31. The Diabetes Group accounted for 7% of the company's business and grew 10% last year, with insulin pump sales growing 30% outside the U.S. The company will accelerate in diabetes, with plans to roll out "more new products in the next 5 years than we have in the last 15 years," said Diabetes Group President Hooman Hakami at an investor day earlier this year.
Recent MDT News
- Medtronic to announce financial results for its fourth quarter and full fiscal year 2024 • PR Newswire (US) • 05/09/2024 12:45:00 PM
- Medtronic to announce financial results for its fourth quarter and full fiscal year 2024 • PR Newswire (Canada) • 05/09/2024 12:45:00 PM
- Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator • PR Newswire (US) • 04/26/2024 11:56:00 AM
- Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator • PR Newswire (Canada) • 04/26/2024 11:56:00 AM
- Americans favor quality over quantity in pursuit of longevity • PR Newswire (Canada) • 04/17/2024 11:02:00 AM
- Americans favor quality over quantity in pursuit of longevity • PR Newswire (US) • 04/17/2024 11:02:00 AM
- Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care • PR Newswire (Canada) • 04/10/2024 12:30:00 PM
- Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care • PR Newswire (US) • 04/10/2024 12:30:00 PM
- The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation • PR Newswire (US) • 04/08/2024 12:00:00 PM
- The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation • PR Newswire (Canada) • 04/08/2024 12:00:00 PM
- SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women • PR Newswire (US) • 04/07/2024 01:45:00 PM
- SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women • PR Newswire (Canada) • 04/07/2024 01:45:00 PM
- New survey uncovers lack of awareness around heart valve disease and risk factors among women • PR Newswire (Canada) • 04/07/2024 12:00:00 PM
- New survey uncovers lack of awareness around heart valve disease and risk factors among women • PR Newswire (US) • 04/07/2024 12:00:00 PM
- Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis • PR Newswire (US) • 03/27/2024 12:00:00 PM
- Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis • PR Newswire (Canada) • 03/27/2024 12:00:00 PM
- U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents • PR Newswire (US) • 03/21/2024 06:51:00 PM
- U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents • PR Newswire (Canada) • 03/21/2024 06:51:00 PM
- New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management • PR Newswire (US) • 03/09/2024 10:40:00 AM
- Medtronic announces cash dividend for fourth quarter of fiscal year 2024 • PR Newswire (US) • 03/07/2024 09:20:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 07:18:56 PM
- Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference • PR Newswire (US) • 03/05/2024 09:30:00 PM
- Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference • PR Newswire (Canada) • 03/05/2024 09:30:00 PM
- Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations • PR Newswire (US) • 02/29/2024 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/27/2024 09:16:45 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM